Back to search

Article

CMAS dampens anti-tumor immunity and associates with response to neoadjuvant immunotherapy in melanoma

2026-04-29

Abstract excerpt

Identifying immune-regulatory pathways to predict response is crucial for the efficacy of immune checkpoint blockade (ICB) immunotherapies. Sialylation is upregulated in tumor cells and modulates immune responses in cancer, yet its impact on patient clinical outcome and the spatial organization of the tumor microenvironment remain unclear. Here, using publicly available single-cell RNA sequencing data we show that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
107c5ac1-2b6f-5766-aff2-5fdf997058a7
DOI
10.64898/2026.04.27.719251
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CMAS dampens anti-tumor immunity and associates with response to neoadjuvant immunotherapy in melanomaDOI 10.64898/2026.04.27.719251
Select a neighboring publication to make it the new centre.